Telix Pharmaceuticals Limited (ASX:TLX)
Australia · Delayed Price · Currency is AUD 13.13
-0.35 (-2.60%)
Oct 30, 2026, 4:13 PM AEDT
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of 4.46 billion as of October 30, 2026. It is the 4,922nd most valuable company in the world and the 97th biggest in Australia. Its market cap has decreased by 18.49% in one year.
Market Cap
4.46B
Enterprise Value
4.94B
Revenue
1.29B
Global Rank
Country Rank
#97 Australia
PE Ratio
95.23
ChartMarket Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from 152.03M to 4.46B, an increase of 2,834.59%. That is a compound annual growth rate of 45.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 4.46B | 17.60% |
| Dec 31, 2025 | 3.79B | -53.95% |
| Dec 31, 2024 | 8.24B | 152.44% |
| Dec 29, 2023 | 3.26B | 41.89% |
| Dec 30, 2022 | 2.30B | 4.10% |
| Dec 31, 2021 | 2.21B | 108.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 94.39B |
| Mesoblast | 2.44B |
| Neuren Pharmaceuticals | 2.40B |
| PYC Therapeutics | 1.94B |
| Clarity Pharmaceuticals | 583.87M |
| Clinuvel Pharmaceuticals | 362.07M |
| Racura Oncology | 297.04M |
| Tetratherix | 291.82M |